We are live on ! Find out more
YCM

Yiheng Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 29.07%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+29.07%
3 Year Est. Return
+63.69%
5 Year Est. Return
+56.64%
10 Year Est. Return
+851.36%
AUM
$678M
AUM Growth
-$433M
Cap. Flow
-$558M
Cap. Flow %
-82.22%
Top 10 Hldgs %
86.3%
Holding
29
New
4
Increased
–
Reduced
9
Closed
2

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.77M
2
CLBT icon
Cellebrite
CLBT
+$3.63M
3
PONY
Pony AI Inc
PONY
+$3.05M

Top Sells

Rank Stock Value
1
BILI icon
Bilibili
BILI
+$12M
2
AKRO
Akero Therapeutics
AKRO
+$5.26M
3
EDU icon
New Oriental
EDU
+$3.76M
4
HTHT icon
Huazhu Hotels Group
HTHT
+$1.11M
5
NOAH
Noah Holdings
NOAH
+$28.3K

Sector Composition

Rank Sector Weight
1 Financials 11.48%
2 Healthcare 9.53%
3 Consumer Discretionary 8.89%
4 Communication Services 5.88%
5 Consumer Staples 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBIO
26
DELISTED
Generation Bio
GBIO
$646K 0.1%
105,524
-3
-0% -$16
TOUR
27
Tuniu
TOUR
$55.6M
$299K 0.04%
31,444
– –
PLNT icon
28
PUT
Planet Fitness
PLNT
$3.96B
– –
-270,000
Closed -$29.4M
ULS icon
29
PUT
UL Solutions
ULS
$15.8B
– –
-841,800
Closed -$61.3M
1
2

Similar funds

PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
WF
Wayfinding Financial Lynnwood, Washington $230M AUM 17.64% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
TRIA
Trail Ridge Investment Advisors Fort Collins, Colorado $230M AUM 22.34% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return

Yiheng Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Yiheng Capital Management held 29 positions worth $678M, down 39% from $1.11B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Yiheng Capital Management withdrew a net $558M in Q3 2025, closing 2 positions and reducing 9 holdings. Its largest reduction was Bilibili, cutting an estimated $12M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 7.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Yiheng Capital Management opened a new position in Ultragenyx Pharmaceutical worth $6.79M.

  • Yiheng Capital Management's largest Q3 2025 buy was Ultragenyx Pharmaceutical: 225,758 shares worth $6.79M.
  • Yiheng Capital Management's biggest Q3 2025 reduction was Bilibili, cutting an estimated $12M.
  • Yiheng Capital Management's ten largest holdings make up 86% of its $678M portfolio in Q3 2025.
  • Yiheng Capital Management opened 4 new positions and closed 2 in Q3 2025.
  • Yiheng Capital Management's portfolio value fell 39% quarter-over-quarter to $678M.

Based on Yiheng Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.